WHO bans solidarity testing of Lopinavir / Ritonavir drugs
The WHO today approved the recommendation of the International Steering Committee to ban the testing of hydroxychloroquine and Lopinavir / Ritonavir.
Geneva: The World Health Organization (WHO) has announced a moratorium on lopinavir/ritonavir drug solidarity testing due to a slight reduction or just a reduction in deaths of hospitalized coronavirus (COVID-19).
The WHO issued a statement on Saturday saying ‘WHO today approved the International Steering Committee’s recommendation to ban the testing of hydroxychloroquine and lopinavir/ritonavir.’ The WHO said that the decision was taken in view of the internal results of a solidarity test of the drugs.
‘After the use of hydroxychloroquine and lopinavir/ritonavir, internal results showed that there was no slight decrease or decrease in the deaths of hospitalized Covid-19 patients’, the WHO said. WHO further said that these drug solidarity tests had immediately been postponed.
However, the organization’s decision will only apply to hospitalized patients. This will not affect the study of patients before hospitalization or after being discharged from the hospital. The organization ahd launched a solidarity test in March to explore its effects on hospitalized patients.